- Home
- »
- Healthcare IT
- »
-
Digital Pathology Market Size & Share Analysis Report, 2030GVR Report cover
![Digital Pathology Market Size, Share & Trends Report]()
Digital Pathology Market Size, Share & Trends Analysis Report By Application (Academic Research, Disease Diagnosis), By Product (Software, Device), By Type, By End-use (Diagnostic Labs, Hospitals), By Region, And Segment Forecasts, 2024 - 2030
- Report ID: 978-1-68038-386-7
- Number of Report Pages: 150
- Format: PDF, Horizon Databook
- Historical Range: 2018 - 2023
- Forecast Period: 2024 - 2030
- Industry: Healthcare
Digital Pathology Market Size & Trends
The global digital pathology market size was valued at USD 1.03 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2030. This is attributed to rising prevalence of cancer, increasing focus on improving the efficiency of workflow, and growing demand for faster diagnostic tools. Moreover, rising investments in healthcare aided by major key players operating in the market focusing on new launches, increasing adoption of telepathology, and an increasing focus on drug discovery and precision medicine is propelling the market growth.
Rising adoption of healthcare IT solutions is fueling the demand for digital pathology solutions. Organizations are increasingly implementing them to cut costs, streamline processes, overcome resource bottlenecks, and facilitate efficient content sharing. A growing necessity for collaborations and the expanding use of digital documentation across various scientific disciplines also drives the demand. In addition, factors such as heightened adoption to enhance laboratory efficiency, a surge in teleconsultations, and increased applications in companion diagnostics and drug discovery are expected to contribute to the market's growth.
During the COVID-19 pandemic, government organizations in various countries, research institutes, and many pharmaceutical & biotech firms focused on effective & rapid technologies for accurate COVID-19 diagnosis and development of vaccines/new therapeutics to combat the pandemic. COVID-19 tested diagnostic services at a time when many histopathology departments were already understaffed and overburdened. Furthermore, it had a significant impact on routine pathology services. During the pandemic, digital pathology was critical in protecting clinical services and pathology-based research.
Market Concentration & Characteristics
The market is currently experiencing significant growth, driven by factors such as the rising prevalence of chronic diseases and rapid technological advancements. The introduction of AI-based tools aligns with the increasing digitalization of pathology reads, highlighting the value of AI and machine learning in standardizing diagnoses, quantifying biomarkers, and ensuring quality control.
For instance, in August 2023, PathAI announced the AISight Digital Pathology Image Management System for the next generation of pathology labs. AISight, a cloud-based platform, streamlines digital pathology workflows, providing advanced image and case management, viewing, ingestion, and seamless integration of AI applications. AISight, a cloud-based platform, streamlines digital pathology workflows, providing advanced image and case management, viewing, ingestion, and seamless integration of AI applications.
“We have been overwhelmed with the positive feedback from pathologists, lab directors, operators, and administrators who have trialed AISight and we’re excited to make it available at scale. AISight provides a one-stop shop for digital pathology case management that is flexible for multiple use cases given its interoperability and configurability. We will continue iterating on new and improved features as we listen to our users and release updates as they become available.”
-Eric Walk, M.D., F.C.A.P., Chief Medical Officer, PathAIIntegration of AI and digital pathology represents a transformative era with remarkable analytical capabilities. Ongoing research focuses on enhancing AI software for digital pathology applications. In addition, AI is being leveraged to improve the analysis of digital images. Previously, pathologists had to manually identify regions of interest within tissue samples, but AI is now automating this process. This shift reduces the reliance on manual labor, minimizing the risk of human error and promoting greater automation in pathology practices.
Table 1 Some of the strategic collaboration related to integration of AI and Digital Pathology
Year
Month
Strategic Development
2022
March
Dedalus Group (“Dedalus”) partnered with Ibex Medical Analytics (“Ibex”), the market leader in artificial intelligence (AI)-powered cancer diagnostics to bring the power of artificial intelligence to digital pathology.
2021
April
Royal Philips and Ibex Medical Analytics strategically collaborated to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide
Mergers and acquisitions within the market are increasing. Companies are strategically utilizing multiple acquisitions to strengthen their product offerings, extend their global reach, diversify portfolios, integrate technologies, and bolster their positions within the industry. For instance, in February 2023, Fujifilm acquired the global digital pathology business of Inspirata, including its Dynamyx digital pathology system.
“Acquiring Inspirata’s digital pathology business allows Fujifilm to be an even stronger healthcare partner-bridging a technological gap between pathology, radiology, and oncology to facilitate a more collaborative approach to care delivery across the enterprise,”
- Fujifilm CEO and president Teiichi Goto
The digital pathology market is regulated by different committees. For instance, for new players in the market. a regulatory committee has been set up by the Digital Pathology Association with an aim to establish a sense of urgency within regulatory agencies and bring clarity to the process of clearance & approval of digital pathology.
Table 2 Digital Pathology Guidelines in North America
Country
List of Organizations
U.S.
Food and Drug Administration (FDA)
Centers for Medicare and Medicaid Services (CMS)
Centers for Disease Control and Prevention (CDC)
College of American Pathologists (CAP)
Canada
Canadian Association of Pathologists
Product Insights
The device segment held the largest share of 51.72% in 2023 and is anticipated to grow at a lucrative growth rate during the projected period. The device segment includes slide management system and scanner. The segment growth is attributed to increasing adoption of digital pathology in academic research activities with enhanced resolution. For instance, in June 2022, F. Hoffmann-La Roche Ltd. received a CE marking for its VENTANA DP 600 slide scanner, a next-generation, high-capacity slide scanner that generates high-resolution digital images of stained tissue samples to aid in cancer diagnosis and treatment planning.
The software segment is expected to register fastest growth rate from 2024 to 2030. This growth is attributed to rising number of cancer cases with key players focusing on the development of novel digital pathology systems in the industry. For instance, in August 2021, Xybion Corp. launched Pristima XD Digital Pathology, which helps in providing improved lab throughput allowing streamlining workflows. In January 2019, F. Hoffmann-La Roche Ltd. launched uPath enterprise software, for improving performance, speed, and use for digital pathology. Such innovative incorporation of integrated software helps in improving workflows.
End-use Insights
The hospitals segment dominated the market in 2023 with a share of 36.7%. Hospitals are the most preferred healthcare setting for disease diagnosis and care. Developments in hospital laboratories are crucial to address the evolving needs of patients with more hospitals aiming to provide a wide range of services within their settings. A number of hospitals are implementing digital scanning techniques to improve patient compliance and speed diagnosis. For instance, in March 2023, Ibex (Ibex Medical Analytics) received a PathLAKE contract to provide AI-enabled solutions at 25 NHS to support cancer diagnosis.
The diagnostic labs segment is expected to grow at the fastest growth rate from 2024 to 2030 owing to increasing focus on drug development, preclinical GLP pathology, and oncology clinical trials. Moreover, increasing prevalence of cancer and the adoption of digital pathology in diagnostics labs is fueling the market growth. For instance, in January 2022, Inform Diagnostics launched FullFocus, a digital pathology viewer developed by Paige in its laboratory to use AI tools that would help in streamlining logistics and allow to achieve faster results.
Type Insights
The human pathology segment held the largest share of around 60.0% in 2023. The adoption of digital pathology to reduce turnaround time for disease diagnosis and enhance lab productivity is fueling segment growth. In addition, the rising prevalence of chronic diseases in humans has increased the demand for digital pathology.
Veterinary digital pathology is anticipated to experience substantial growth over the forecast period. The implementation of digital pathology in the veterinary sector is facilitated by fewer restrictions on veterinary diagnoses using virtual scanned slides. Furthermore, the proactive push for automation is driving the demand for the use of digital pathology in the veterinary field.
Regional Insights
North America dominated overall market in 2023 with a share of 40.7% due to increasing government initiatives leading to the development of technologically advanced pathologies, continual deployment of R&D investments, rising adoption of digital imaging, and presence of key market players in the region focusing on providing better solutions to the population. For instance, in March 2023, PathAI launched AISight, a digital pathology platform across the U.S. in 13 leading health systems, reference laboratories, medical centers, and independent pathology organizations to participate in Early Access Program. Moreover, increasing usage of digital pathology in academic research and disease diagnosis is propelling the market growth.
Asia Pacific is expected to grow at the fastest CAGR from 2024 to 2030. This growth is attributed to rapid digitalization, a rising focus on investments in the medical field, and a rising digital imaging penetration in developing economies. The region shows an increasing prevalence of cancer, which propels the need for novel treatment options, further boosting market growth. In March 2023, Qritive entered into collaboration with Corista for the integration of AI using the company’s DP3, a DICOM-compliant pathology software in digital pathology. Such initiatives help in providing better patient care, with novel treatment options, and subsequently reducing laboratory cost expenses.
Application Insights
The academic research segment dominated the market in 2023 with a share of 45.7% and is anticipated to remain dominant from 2024 to 2030 owing to the continual research in the development of cancer therapies and high adoption of digital pathology in various research studies. A number of academic research institutes are collaborating with digital pathology providers to incorporate the technology into research activities. In November 2022, the University Medical Center Utrecht entered into a partnership with Paige for the deployment of the company’s application in clinical use and to conduct a clinical health economics study to support reimbursement and adoption of AI applications in pathology.
Disease diagnosis is anticipated to witness the fastest growth rate from 2024 to 2030 owing to increasing prevalence of chronic diseases, and increasing focus of manufacturers for the development of rapid and novel diagnostics techniques for ease in the circulation of inter and intra-departmental information. Digital adoption of technologies helps in improving and enhancing the efficiency of disease diagnosis and, hence, improving therapeutics. For instance, in April 2022, PreciseDx entered into collaboration with The Michael J. Fox Foundation for the launch of AI-enabled digital pathology technology for the diagnosis of Parkinson's disease before severe symptoms are seen in patients.
Key Companies & Market Share Insights
The market is experiencing notable growth owing to rising collaboration, mergers, and product launches. Few notable players in the market includes Leica Biosystems Nussloch GmbH (Danaher), Olympus Corporation, Hamamatsu Photonics, Inc., and F. Hoffmann-La Roche Ltd; CellaVision;Hangzhou Zhiwei Information Technology Co. Ltd. (Morphogo);aetherAI; Morphle Labs, Inc.; Visiopharm A/S; etc.
In July 2022, CellaVision introduced the DIFF-Line, a workflow system designed specifically for low-volume hematology laboratories, at the AACC Convention, Chicago, U.S. This solution consists of three instruments, including the CellaVision DC-1, RAL SmearBox, and RAL StainBox, which are used for smearing, staining, and analyzing peripheral blood smears. This technology was made available in the European markets in July 2022, with plans to expand to other regions in the same year.
"DIFF-Line by CellaVision is a comprehensive solution for small labs that want to improve diagnostic certainty. With the acquisition of RAL Diagnostics, CellaVision can now offer a complete workflow for smearing, staining, and analyzing peripheral blood smears in hematology labs that handle a smaller amount of daily blood samples.”
- Simon Ostergaard, CellaVision CEO,
In February 2020, Scopio Labs, a company dedicated to advancing digital microscopy, announced the launch of ScopioVet Digital Cytology System in the United States and Canada. It is the first true end-to-end solution for veterinary digital cytology, consisting of Scopio's proprietary microscopy imaging system, an intuitive pathology consultation service and powerful AI tools that automate routine diagnostic tests.
"The diagnostic practice of cytology and hematology is designed to be a less invasive and significantly faster option than histology. However, when veterinarians and pet parents wait several days for results to come back, as is the case in most veterinary practices worldwide, the value of cytology is reduced. ScopioVet corrects this dynamic, by providing results in less than an hour, unlocking the true value of cytology and improving the standard of care so veterinarians can deliver exceptional service with improved outcomes."
- Asher Fink, Veterinary Business Head and VP of Business Development for Scopio Labs.
Key Digital Pathology Companies:
- Leica Biosystems Nussloch GmbH (Danaher)
- Hamamatsu Photonics, Inc.
- Koninklijke Philips N.V.
- Olympus Corporation
- F. Hoffmann-La Roche Ltd.
- Mikroscan Technologies, Inc.
- Inspirata, Inc.
- Epredia (3DHISTECH Ltd.)
- Visiopharm A/S
- Huron Technologies International Inc.
- ContextVision AB
- CellaVision
- HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
- West Medica Produktions- und Handels- GmbH (West Medica)
- aetherAI
- IBEX (IBEX MEDICAL ANALYTICS)
- SigTuple Technologies Private Limited
- Morphle Labs, Inc
- Bionovation Biotech, Inc.
Recent Developments
-
In October 2023, Pramana and Gestalt announced the availability of an integrated AI-powered platform and digital pathology solutions, combining digital pathology, AI, image analysis, and DICOM into a streamlined, single, comprehensive offering.
“The relationship between Gestalt and Pramana has evolved quickly due to our combined commitment to bring advanced technological solutions to healthcare that improve accuracy, efficiency, and stay on top of technological advancements.“As DICOM becomes more prevalent and the benefits for use in diagnostic and research workflows are being realized, we are continually evolving to provide solutions that support pathologists, scientists, and academics. Working with partners like Pramana, who have similar goals, is what progresses pathology informatics and expands availability and access, advancing healthcare globally.” The companies’ integrated platform enables fast, accurate, and automated slide scanning with the AI algorithm and image analysis during the processing phase. The algorithm is available for use within Gestalt’s platform, or others, in keeping with Gestalt’s philosophy of being vendor agnostic.
- Lisa-Jean Clifford, Gestalt COO and Chief Strategy Officer
-
In September 2022, Paige entered into collaboration with OptraSCAN for streamlining the adoption of digital pathology technology in the European Union, U.S., and UK. The aim of this partnership is to enhance workflows of oncology and pathology by reducing the barriers to digitizing glass pathology slides.
Digital Pathology Market Report Scope
Report Attribute
Details
Market size value in 2024
USD 1.10 billion
Revenue forecast in 2030
USD 1.73 billion
Growth rate
CAGR of 8.0% from 2024 to 2030
Actual data
2018 - 2023
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million/billion and CAGR from 2024 to 2030
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, type, application, end-use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; India; China; Japan; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; UAE; South Africa; Kuwait
Key companies profiled
Leica Biosystems Nussloch GmbH (Danaher); Hamamatsu Photonics, Inc.; Koninklijke Philips N.V.; Olympus Corp.; F. Hoffmann-La Roche Ltd.; Mikroscan Technologies, Inc.; Inspirata, Inc.; Epredia (3DHISTECH Ltd.); Visiopharm A/S; Huron Technologies International Inc.; ContextVision AB; HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO); West Medica Produktions- und Handels- GmbH (West Medica); aetherAI; IBEX (IBEX MEDICAL ANALYTICS); SigTuple Technologies Private Limited; Morphle Labs, Inc; Bionovation Biotech, Inc.
Customization scope
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Digital Pathology Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global digital pathology market based on product, type, application, end-use, and region:
-
Product Outlook (Revenue, USD Billion, 2018 - 2030)
-
Software
-
Device
-
Scanners
-
Slide Management System
-
-
Storage System
-
- Type Outlook (Revenue, USD Billion, 2018 - 2030)
-
Human Pathology
-
Veterinary Pathology
-
-
Application Outlook (Revenue, USD Billion, 2018 - 2030)
-
Drug Discovery & Development
-
Academic Research
-
Disease Diagnosis
-
Cancer Cell Detection
-
Others
-
-
-
End-use Outlook (Revenue, USD Billion, 2018 - 2030)
-
Hospitals
-
Biotech & Pharma Companies
-
Diagnostic Labs
-
Academic & Research Institutes
-
-
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
ROE
-
-
Asia Pacific
-
Japan
-
China
-
India
-
South Korea
-
Australia
-
Thailand
-
RoAPAC
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
RoLATAM
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
b. The global digital pathology market size was estimated at USD 1.03 billion in 2023 and is expected to reach USD 1.10 billion in 2024.
b. The global digital pathology market is expected to grow at a compound annual growth rate of 8.0% from 2024 to 2030 to reach USD 1.73 billion by 2030.
b. North America dominated the digital pathology market with a share of 40.75% in 2023. This is attributable to the deployment of R&D investments, supportive government initiatives, technologically advanced systems, rising adoption of digital imaging, and the presence of major players.
b. Some key players operating in the digital pathology market include Omynx LLC; 3DHistech, Inc.; Definiens; Olympus Corporation; GE Healthcare; Leica Biosystems; Philips Healthcare; Ventana Medical Systems, Inc.; Objective Pathology Services; Hamamatsu Photonics, Inc.; LigoLAb LLC; and MicroSkan Technologies.
b. Key factors that are driving the digital pathology market growth include increasing focus on improving workflow efficiency and demand for faster diagnostic tools for chronic diseases and the prevalence of chronic conditions.
Table of Contents
Chapter 1. Digital Pathology Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database:
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research:
1.3.5. Details Of Primary Research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for Primary Interviews in Europe
1.3.5.3. Data for Primary Interviews in APAC
1.3.5.4. Data for Primary Interviews in Latin America
1.3.5.5. Data for Primary Interviews in MEA
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity Flow Analysis
1.6.2. Top down market estimation
1.6.3. CAGR Calculation
1.6.4. Key Report Updates
1.7. List of Secondary Sources
1.8. List of Abbreviations
1.9. Report Objectives
1.9.1. Objective - 1
1.9.2. Objective - 2
Chapter 2. Digital Pathology Market: Executive Summary
2.1. Market Snapshot
2.2. Segmental Snapshot
2.3. Competitive Insights Snapshot
Chapter 3. Digital Pathology Market: Variables, Trends, and Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Analysis
3.1.2. Ancillary Market Analysis
3.2. Digital Pathology Market- Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence Of Chronic Diseases
3.2.1.2. Rapid Technological Advancement
3.2.1.2.1. AI integration
3.2.2. Market Restraint Analysis
3.2.2.1. Lack Of Reimbursement For Digital Pathology-Enabled Services
3.2.2.2. Lack of Skilled Professionals
3.2.3. Industry Challenges
3.3. Digital Pathology Market Analysis Tools: Porters
3.4. PESTLE Analysis
3.5. Technology Trend Analysis
3.6. Regulatory Framework
3.7. Cost Structure Analysis
3.8. User Perspective Analysis
3.9. Case Studies
3.10. COVID 19 Impact
Chapter 4. Digital Pathology Market: Product Type Estimates & Trend Analysis
4.1. Digital Pathology Market, Product Type: Key Takeaways
4.2. Digital Pathology Market: Product Type Movement & Market Share Analysis, 2022 & 2030
4.3. Software
4.3.1. Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.3.2. Integrated Software
4.3.2.1. Integrated Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.3.3. Standalone Software
4.3.3.1. Standalone Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.4. Devices
4.4.1. Devices Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.4.2. Scanners
4.4.2.1. Scanners market estimates and forecast, 2018 - 2030 (USD Million)
4.4.2.2. Brightfield Scanners
4.4.2.2.1. Brightfield Scanners market estimates and forecast, 2018 - 2030 (USD Million)
4.4.2.3. Fluroscence Scanners
4.4.2.3.1. Fluroscence Scanners market estimates and forecast, 2018 - 2030 (USD Million)
4.4.2.4. Others
4.4.2.4.1. Others Scanner market estimates and forecast, 2018 - 2030 (USD Million)
4.4.3. Slide Management System
4.4.3.1. Slide management system market estimates and forecast, 2018 - 2030 (USD Million)
4.5. Storage Systems
4.5.1. Storage Systems Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Digital Pathology Market: Type Estimates & Trend Analysis
5.1. Digital Pathology Market, by Type: Key Takeaways
5.2. Digital Pathology Market: Type Movement & Market Share Analysis, 2022 & 2030
5.3. Veterinary Pathology
5.3.1. Veterinary Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
5.4. Human Pathology
5.4.1. Human Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Application Estimates & Trend Analysis
6.1. Digital Pathology Market, Application Type: Key Takeaways
6.2. Digital Pathology Market: Application Movement & Market Share Analysis, 2022 & 2030
6.3. Drug Discovery & Development
6.3.1. Drug Discovery & Development Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
6.4. Academic Research
6.4.1. Academic Research Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
6.5. Disease Diagnosis
6.5.1. Disease Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
6.5.2. Cancer Cell Detection
6.5.2.1. Cancer Cell Detection Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
6.5.3. Others
6.5.3.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Digital Pathology Market: End Use Estimates & Trend Analysis
7.1. Digital Pathology Market, By End Use: Key Takeaways
7.2. Digital Pathology Market: End Use Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals
7.3.1. Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4. Biotech & Pharma Companies
7.4.1. Biotech & Pharma Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Diagnostics Labs
7.5.1. Diagnostics Labs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. Academic & Research Institutes
7.6.1. Academic & Research Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Digital Pathology Market: Country Estimates & Trend Analysis
8.1 Digital Pathology Market: Regional Movement Analysis, 2022 & 2030
8.1.1 North America
8.1.1.1 North America Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 Key Country Dynamics
8.1.1.2.2 Competitive Scenario
8.1.1.2.3 Regulatory Framework
8.1.1.2.4 Reimbursement Scenario
8.1.1.2.5 U.S. Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Key Country Dynamics
8.1.1.3.2 Competitive Scenario
8.1.1.3.3 Regulatory Framework
8.1.1.3.4 Reimbursement Scenario
8.1.1.3.5 Canada Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.2 Europe
8.1.2.1 Europe Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.2.2 UK
8.1.2.2.1 Key Country Dynamics
8.1.2.2.2 Competitive Scenario
8.1.2.2.3 Regulatory Framework
8.1.2.2.4 Reimbursement Scenario
8.1.2.2.5 UK Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Key Country Dynamics
8.1.2.3.2 Competitive Scenario
8.1.2.3.3 Regulatory Framework
8.1.2.3.4 Reimbursement Scenario
8.1.2.3.5 Germany Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.2.4 France
8.1.2.4.1 Key Country Dynamics
8.1.2.4.2 Competitive Scenario
8.1.2.4.3 Regulatory Framework
8.1.2.4.4 Reimbursement Scenario
8.1.2.4.5 France Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.2.5 Italy
8.1.2.5.1 Key Country Dynamics
8.1.2.5.2 Competitive Scenario
8.1.2.5.3 Regulatory Framework
8.1.2.5.4 Reimbursement Scenario
8.1.2.5.5 Italy Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.2.6 Spain
8.1.2.6.1 Key Country Dynamics
8.1.2.6.2 Competitive Scenario
8.1.2.6.3 Regulatory Framework
8.1.2.6.4 Reimbursement Scenario
8.1.2.6.5 Spain Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.2.7 Denmark
8.1.2.7.1 Key Country Dynamics
8.1.2.7.2 Competitive Scenario
8.1.2.7.3 Regulatory Framework
8.1.2.7.4 Reimbursement Scenario
8.1.2.7.5 Denmark Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.2.8 Sweden
8.1.2.8.1 Key Country Dynamics
8.1.2.8.2 Competitive Scenario
8.1.2.8.3 Regulatory Framework
8.1.2.8.4 Reimbursement Scenario
8.1.2.8.5 Sweden Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.2.9 Norway
8.1.2.9.1 Key Country Dynamics
8.1.2.9.2 Competitive Scenario
8.1.2.9.3 Regulatory Framework
8.1.2.9.4 Reimbursement Scenario
8.1.2.9.5 Norway Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Key Country Dynamics
8.1.3.2.2 Competitive Scenario
8.1.3.2.3 Regulatory Framework
8.1.3.2.4 Reimbursement Scenario
8.1.3.2.5 Japan Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.3.3 India
8.1.3.3.1 Key Country Dynamics
8.1.3.3.2 Competitive Scenario
8.1.3.3.3 Regulatory Framework
8.1.3.3.4 Reimbursement Scenario
8.1.3.3.5 India Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.3.4 China
8.1.3.4.1 Key Country Dynamics
8.1.3.4.2 Competitive Scenario
8.1.3.4.3 Regulatory Framework
8.1.3.4.4 Reimbursement Scenario
8.1.3.4.5 China Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.3.5 Australia
8.1.3.5.1 Key Country Dynamics
8.1.3.5.2 8. 6. 3.5competitive Scenario
8.1.3.5.3 Regulatory Framework
8.1.3.5.4 Reimbursement Scenario
8.1.3.5.5 Australia Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.3.6 Thailand
8.1.3.6.1 Key Country Dynamics
8.1.3.6.2 Competitive Scenario
8.1.3.6.3 Regulatory Framework
8.1.3.6.4 Reimbursement Scenario
8.1.3.6.5 Thailand Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.3.7 South Korea
8.1.3.7.1 Key Country Dynamics
8.1.3.7.2 Competitive Scenario
8.1.3.7.3 Regulatory Framework
8.1.3.7.4 Reimbursement Scenario
8.1.3.7.5 South Korea Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Key Country Dynamics
8.1.4.2.2 Competitive Scenario
8.1.4.2.3 Regulatory Framework
8.1.4.2.4 Reimbursement Scenario
8.1.4.2.5 Brazil Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Key Country Dynamics
8.1.4.3.2 Competitive Scenario
8.1.4.3.3 Regulatory Framework
8.1.4.3.4 Reimbursement Scenario
8.1.4.3.5 Mexico Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Key Country Dynamics
8.1.4.4.2 Competitive Scenario
8.1.4.4.3 Regulatory Framework
8.1.4.4.4 Reimbursement Scenario
8.1.4.4.5 Argentina Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.5 MEA
8.1.5.1 MEA Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.5.2 South Africa
8.1.5.2.1 Key Country Dynamics
8.1.5.2.2 Competitive Scenario
8.1.5.2.3 Regulatory Framework
8.1.5.2.4 Reimbursement Scenario
8.1.5.2.5 South Africa Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.5.3 Saudi Arabia
8.1.5.3.1 Key Country Dynamics
8.1.5.3.2 Competitive Scenario
8.1.5.3.3 Regulatory Framework
8.1.5.3.4 Reimbursement Scenario
8.1.5.3.5 Saudi Arabia Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.5.4 UAE
8.1.5.4.1 Key Country Dynamics
8.1.5.4.2 Competitive Scenario
8.1.5.4.3 Regulatory Framework
8.1.5.4.4 Reimbursement Scenario
8.1.5.4.5 UAE Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.1.5.5 Kuwait
8.1.5.5.1 Key Country Dynamics
8.1.5.5.2 Competitive Scenario
8.1.5.5.3 Regulatory Framework
8.1.5.5.4 Reimbursement Scenario
8.1.5.5.5 Kuwait Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Competitive Market Entry Strategies
9.3. Private Companies/ Vendors, By Country/Region
9.4. Company Market Share Analysis, 2023
9.5. Strategy Mapping
9.6. Company Profiles/Listing
9.6.1. Leica Biosystems Nussloch GmbH (Danaher)
9.6.1.1. Overview
9.6.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.1.3. Product Benchmarking
9.6.1.4. Strategic Initiatives
9.6.2. Hamamatsu Photonics, Inc
9.6.2.1. Overview
9.6.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.2.3. Product Benchmarking
9.6.2.4. Strategic Initiatives
9.6.3. Koninklijke Philips N.V.
9.6.3.1. Overview
9.6.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.3.3. Product Benchmarking
9.6.3.4. Strategic Initiatives
9.6.4. Olympus Corporation
9.6.4.1. Overview
9.6.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.4.3. Product Benchmarking
9.6.4.4. Strategic Initiatives
9.6.5. F. Hoffmann-La Roche Ltd
9.6.5.1. Overview
9.6.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.5.3. Product Benchmarking
9.6.5.4. Strategic Initiatives
9.6.6. Mikroscan Technologies, Inc
9.6.6.1. Overview
9.6.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.6.3. Product Benchmarking
9.6.6.4. Strategic Initiatives
9.6.7. Inspirata, Inc.
9.6.7.1. Overview
9.6.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.7.3. Product Benchmarking
9.6.7.4. Strategic Initiatives
9.6.8. Epredia (3DHISTECH Ltd.)
9.6.8.1. Overview
9.6.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.8.3. Product Benchmarking
9.6.8.4. Strategic Initiatives
9.6.9. Visiopharm A/S
9.6.9.1. Overview
9.6.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.9.3. Product Benchmarking
9.6.9.4. Strategic Initiatives
9.6.10. Huron Technologies International Inc.
9.6.10.1. Overview
9.6.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.10.3. Product Benchmarking
9.6.10.4. Strategic Initiatives
9.6.11. ContextVision AB
9.6.11.1. Overview
9.6.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.11.3. Product Benchmarking
9.6.11.4. Strategic Initiatives
9.6.12. CellaVision
9.6.12.1. Overview
9.6.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.12.3. Product Benchmarking
9.6.12.4. Strategic Initiatives
9.6.13. Hangzhou Zhiwei Information Technology Co. Ltd. (Morphogo)
9.6.13.1. Overview
9.6.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.13.3. Product Benchmarking
9.6.13.4. Strategic Initiatives
9.6.14. West Medica Produktions- und Handels- GmbH (West Medica)
9.6.14.1. Overview
9.6.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.14.3. Product Benchmarking
9.6.14.4. Strategic Initiatives
9.6.15. aetherAI
9.6.15.1. Overview
9.6.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.15.3. Product Benchmarking
9.6.15.4. Strategic Initiatives
9.6.16. Ibex (Ibex Medical Analytics)
9.6.16.1. Overview
9.6.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.16.3. Product Benchmarking
9.6.16.4. Strategic Initiatives
9.6.17. SigTuple Technologies Private Limited
9.6.17.1. Overview
9.6.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.17.3. Product Benchmarking
9.6.17.4. Strategic Initiatives
9.6.18. Morphle Labs, Inc
9.6.18.1. Overview
9.6.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.18.3. Product Benchmarking
9.6.18.4. Strategic Initiatives
9.6.19. Bionovation Biotech, Inc
9.6.19.1. Overview
9.6.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.19.3. Product Benchmarking
9.6.19.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Digital Pathology Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 5 Global Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 6 Global Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 7 Global Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 8 North America Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 10 North America Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 11 North America Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 12 North America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 13 U.S. Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 14 U.S. Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 15 U.S. Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 16 U.S. Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 17 Canada Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 18 Canada Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 19 Canada Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 20 Canada Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 21 Europe Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
Table 22 Europe Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 23 Europe Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 24 Europe Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 25 Europe Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 26 UK Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 27 UK Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 28 UK Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 29 UK Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 30 Germany Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 31 Germany Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 32 Germany Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 33 Germany Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 34 France Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 35 France Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 36 France Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 37 France Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 38 Italy Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 39 Italy Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 40 Italy Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 41 Italy Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 42 Spain Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 43 Spain Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 44 Spain Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 45 Spain Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 46 Denmark Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 47 Denmark Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 48 Denmark Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 49 Denmark Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 50 Norway Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 51 Norway Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 52 Norway Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 53 Norway Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 54 Sweden Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 55 Sweden Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 56 Sweden Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 57 Sweden Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 63 Japan Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 64 Japan Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 65 Japan Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 66 Japan Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 67 China Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 68 China Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 69 China Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 70 China Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 71 India Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 72 India Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 73 India Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 74 India Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 75 South Korea Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 76 South Korea Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 77 South Korea Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 78 South Korea Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 79 Australia Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 80 Australia Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 81 Australia Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 82 Australia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 83 Thailand Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 84 Thailand Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 85 Thailand Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 86 Thailand Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 87 Latin America Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
Table 88 Latin America Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 89 Latin America Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 90 Latin America Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 91 Latin America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 92 Brazil Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 93 Brazil Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 94 Brazil Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 95 Brazil Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 96 Argentina Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 97 Argentina Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 98 Argentina Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 99 Argentina Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 100 Mexico Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 101 Mexico Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 102 Mexico Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 103 Mexico Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 104 Middle East and Africa Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
Table 105 Middle East and Africa Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 106 Middle East and Africa Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 107 Middle East and Africa Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 108 Middle East and Africa Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 109 South Africa Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 110 South Africa Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 111 South Africa Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 112 South Africa Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 117 UAE Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 118 UAE Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 119 UAE Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 120 UAE Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
Table 121 Kuwait Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
Table 122 Kuwait Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
Table 123 Kuwait Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
Table 124 Kuwait Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Digital Pathology Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s Five Forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Digital pathology market: Product movement analysis
Fig. 17 Digital pathology market: Product segment dashboard
Fig. 18 Digital pathology market product outlook: Key takeaways
Fig. 19 Software market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Integrated Software market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Standalone Software market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Device market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Storage system market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Digital pathology market: Type movement analysis
Fig. 25 Digital pathology market: Type segment dashboard
Fig. 26 Digital pathology market type outlook: Key takeaways
Fig. 27 Human digital pathology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Veterinary digital pathology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Digital pathology market: Application movement analysis
Fig. 30 Digital pathology market: Application segment dashboard
Fig. 31 Digital pathology market application outlook: Key takeaways
Fig. 32 Drug discovery & development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Academic research market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Disease diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Digital pathology market: End-use movement analysis
Fig. 36 Digital pathology market: End-use segment dashboard
Fig. 37 Digital pathology market end-use outlook: Key takeaways
Fig. 38 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Biotech & pharma companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Academic &research institutes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Regional outlook, 2023 & 2030
Fig. 43 Regional market dashboard
Fig. 44 Regional market place: Key takeaways
Fig. 45 North America, SWOT
Fig. 46 Europe, SWOT
Fig. 47 Asia Pacific, SWOT
Fig. 48 Latin America, SWOT
Fig. 49 Middle East and Africa, SWOT
Fig. 50 North America
Fig. 51 North America Digital pathology market, 2018 - 2030 (USD Million)
Fig. 52 U.S.
Fig. 53 U.S. Digital pathology market, 2018 - 2030 (USD Million)
Fig. 54 Canada
Fig. 55 Canada Digital pathology market, 2018 - 2030 (USD Million)
Fig. 56 Europe
Fig. 57 Europe Digital pathology market, 2018 - 2030 (USD Million)
Fig. 58 UK
Fig. 59 UK Digital pathology market, 2018 - 2030 (USD Million)
Fig. 60 Germany
Fig. 61 Germany Digital pathology market, 2018 - 2030 (USD Million)
Fig. 62 Spain
Fig. 63 Spain Digital pathology market, 2018 - 2030 (USD Million)
Fig. 64 France
Fig. 65 France Digital pathology market, 2018 - 2030 (USD Million)
Fig. 66 Italy
Fig. 67 Italy Digital pathology market, 2018 - 2030 (USD Million)
Fig. 68 Denmark
Fig. 69 Denmark Digital pathology market, 2018 - 2030 (USD Million)
Fig. 70 Norway
Fig. 71 Norway Digital pathology market, 2018 - 2030 (USD Million)
Fig. 72 Sweden
Fig. 73 Sweden Digital pathology market, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific Digital pathology market, 2018 - 2030 (USD Million)
Fig. 76 Japan
Fig. 77 Japan Digital pathology market, 2018 - 2030 (USD Million)
Fig. 78 China
Fig. 79 China Digital Pathology market, 2018 - 2030 (USD Million)
Fig. 80 India
Fig. 81 India Digital pathology market, 2018 - 2030 (USD Million)
Fig. 82 South Korea
Fig. 83 South Korea Digital Pathology market, 2018 - 2030 (USD Million)
Fig. 84 Australia
Fig. 85 Australia Digital pathology market, 2018 - 2030 (USD Million)
Fig. 86 Thailand
Fig. 87 Thailand Digital pathology market, 2018 - 2030 (USD Million)
Fig. 88 Latin America
Fig. 89 Latin America Digital pathology market, 2018 - 2030 (USD Million)
Fig. 90 Brazil
Fig. 91 Brazil Digital pathology market, 2018 - 2030 (USD Million)
Fig. 92 Mexico
Fig. 93 Mexico Digital pathology market, 2018 - 2030 (USD Million)
Fig. 94 Argentina
Fig. 95 Argentina Digital pathology market, 2018 - 2030 (USD Million)
Fig. 96 Middle East and Africa
Fig. 97 MEA Digital pathology market, 2018 - 2030 (USD Million)
Fig. 98 South Africa
Fig. 99 South Africa Digital pathology market, 2018 - 2030 (USD Million)
Fig. 100 Saudi Arabia
Fig. 101 Saudi Arabia Digital pathology market, 2018 - 2030 (USD Million)
Fig. 102 UAE
Fig. 103 UAE Digital pathology market, 2018 - 2030 (USD Million)
Fig. 104 Kuwait
Fig. 105 Kuwait Digital pathology market, 2018 - 2030 (USD Million)Market Segmentation
- Digital Pathology Product Outlook (Revenue, USD Billion, 2018 - 2030)
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Digital Pathology Application Outlook (Revenue, USD Million, 2018 - 2030)
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Digital Pathology End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Digital Pathology Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- North America Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- North America Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- U.S.
- U.S. Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- U.S. Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- U.S. Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- U.S. Digital Pathology Market, By Product
- Canada
- Canada Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Canada Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Canada Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Canada Digital Pathology Market, By Product
- North America Digital Pathology Market, By Product
- Europe
- Europe Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Europe Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Europe Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- UK
- UK Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- UK Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- UK Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- UK Digital Pathology Market, By Product
- Germany
- Germany Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Germany Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Germany Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Germany Digital Pathology Market, By Product
- France
- France Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- France Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- France Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- France Digital Pathology Market, By Product
- Italy
- Italy Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Italy Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Italy Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Italy Digital Pathology Market, By Product
- Spain
- Spain Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Spain Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Spain Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Spain Digital Pathology Market, By Product
- Denmark
- Denmark Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Denmark Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Denmark Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Denmark Digital Pathology Market, By Product
- Norway
- Norway Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Norway Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Norway Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Norway Digital Pathology Market, By Product
- Sweden
- Sweden Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Sweden Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Sweden Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Sweden Digital Pathology Market, By Product
- Europe Digital Pathology Market, By Product
- Asia Pacific
- Asia Pacific Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Asia Pacific Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Asia Pacific Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Japan
- Japan Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Japan Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Japan Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Japan Digital Pathology Market, By Product
- China
- China Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- China Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- China Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- China Digital Pathology Market, By Product
- India
- India Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- India Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- India Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- India Digital Pathology Market, By Product
- South Korea
- South Korea Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- South Korea Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- South Korea Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- South Korea Digital Pathology Market, By Product
- Australia
- Australia Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Australia Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Australia Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Australia Digital Pathology Market, By Product
- Thailand
- Thailand Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Thailand Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Thailand Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Thailand Digital Pathology Market, By Product
- Asia Pacific Digital Pathology Market, By Product
- Latin America
- Latin America Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Latin America Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Latin America Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Brazil
- Brazil Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Brazil Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Brazil Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Brazil Digital Pathology Market, By Product
- Argentina
- Argentina Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Argentina Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Argentina Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Argentina Digital Pathology Market, By Product
- Mexico
- Mexico Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Mexico Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Mexico Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Mexico Digital Pathology Market, By Product
- Latin America Digital Pathology Market, By Product
- Middle East and Africa
- Middle East and Africa Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Middle East and Africa Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Middle East and Africa Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- South Africa
- South Africa Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- South Africa Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- South Africa Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- South Africa Digital Pathology Market, By Product
- Saudi Arabia
- Saudi Arabia Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Saudi Arabia Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Saudi Arabia Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Saudi Arabia Digital Pathology Market, By Product
- UAE
- UAE Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- UAE Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- UAE Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- UAE Digital Pathology Market, By Product
- Kuwait
- Kuwait Digital Pathology Market, By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
- Kuwait Digital Pathology Market, By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
- Kuwait Digital Pathology Market, By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
- Kuwait Digital Pathology Market, By Product
- Middle East and Africa Digital Pathology Market, By Product
- North America
Digital Pathology Market Dynamics
Driver: Increasing Prevalence Of Chronic Diseases
The increasing prevalence of chronic diseases such as cancer predominantly drives the digital pathology market growth. Due to the rising prevalence of cancer, pathology data is necessary for pathologists for enhancing personalized individual cancer therapy for patients. The pathologists are increasingly opting for digital pathology primarily because it increases the diagnostic accuracy, provides therapeutic recommendations, and accelerates the rate of diagnosis to improve patient outcomes. To efficiently diagnose a cancer, researchers as well as pathologists require vastly efficient biomarker quantification tool that significantly increases the importance of digital pathology, which helps automate image analysis and proves greatly beneficial in genetic, functional, and molecular characterization of tumors.
Driver: Higher Cost Efficiency
Digital pathology produces faster and accurate diagnosis and detection of chronic diseases. The tumors are detected automatically at the proliferating and inflammatory stromal cells stage, thereby greatly reducing costs of detection of infected cells. Digital pathology also proves economical as it reduces FISH tests and has a positive impact on the laboratory workflow. The information generated through digital pathology is represented in online slides, which can be accessed through a computer display. It also proves to be a very efficient form of vital information sharing as the data generated through it can be accessed via the net, which supports the research community, publications, diagnostics, and education.
Restraint: Lack Of Skilled Professionals
Developed countries are facing scarcity of skilled professionals in the field of digital pathology, which is among the factors restraining the growth of the market. According to American Society for Clinical Pathology in 2017, the Department of LIS/QA/PI had a vacancy rate of 10.98% for medical laboratories, which was the highest. In the coming five years, the retirement rate is approximately estimated to be 28.30%, which is on the higher side. Outsourcing is being increasingly preferred by the U.S. companies, which is expected to hinder the growth over the coming years.
What Does This Report Include?
This section will provide insights into the contents included in this digital pathology market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Digital pathology market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Digital pathology market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
Research Methodology
A three-pronged approach was followed for deducing the digital pathology market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for digital pathology market to gather the most reliable and current information possible.
- We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
- We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
- We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
- We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
- We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of digital pathology market data depending on the type of information we’re trying to uncover in our research.
-
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
-
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
-
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
-
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
-
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
-
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
-
This step also entails the finalization of the report scope and data representation pattern.
-
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
Digital Pathology Market Categorization:
The digital pathology market was categorized into five segments, namely product (Software, Device, Storage System), type (Human Pathology, Veterinary Pathology), application (Drug Discovery & Development, Academic Research, Disease Diagnosis), end-use (Hospitals, Biotech & Pharma Companies, Diagnostic Labs, Academic & Research Institutes), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
Segment Market Methodology:
The digital pathology market was segmented into product, type, application, end-use and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Market research approaches: Bottom-up
-
Demand estimation of each product across countries/regions summed up to from the total market.
-
Variable analysis for demand forecast.
-
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
-
Primary interviews for data revalidation and insight collection.
Market research approaches: Top-down
-
Used extensively for new product forecasting or analyzing penetration levels.
-
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
-
Primary interviews and vendor-based primary research for variable impact analysis.
Market research approaches: Combined
- This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.
Regional Market Methodology:
The digital pathology market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; India; China; Japan; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; UAE; South Africa; Kuwait.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
Digital pathology market companies & financials:
The digital pathology market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
-
Leica Biosystems (Danaher) - Leica Biosystems provides advanced cancer diagnostics and anatomical pathology services. The company has manufacturing facilities in seven countries and an international dealers’ network. It provides anatomical pathology laboratories and researchers a broad range of technologies for every pathology process, involving preparing sample to imaging, analysis, and reporting, which helps improve efficiency of diagnostics and workflow. The company is a division of Danaher Corporation.
-
Hamamatsu Photonics, Inc . - Hamamatsu Photonics, Inc. is a manufacturer of semiconductors, imaging devices, light sources, imaging & analyzing systems, and photomultiplier tubes. The company also offers X-ray detectors & sources, nondestructive inspection, pharmaceutical development, and academic research.
-
Koninklijke Philips N.V. - Koninklijke Philips N.V. is a health technology company. The healthcare business comprises four segments: imaging systems, patient care, clinical informatics, and home healthcare solutions. Home healthcare solutions includes respiratory care, sleep management & noninvasive ventilation, medical alert, remote patient monitoring, and medication dispensing services.
-
Olympus Corporation – Olympus Corporation’s medical business utilizes innovative capabilities in precision manufacturing and medical technology to deliver therapeutic, minimally invasive procedures, advanced diagnostic to healthcare professionals.
-
F. Hoffmann-La Roche Ltd -Roche operates its business in the digital pathology market through Ventana Medical Systems, Inc. after acquiring it in 2008. The company has expertise in in vitro diagnostics, diabetes management, and tissue-based cancer diagnostics. Roche is a pioneer in diagnostics and pharmaceuticals focused on advancing science to improve health.
-
Mikroscan Technologies, Inc. - offers digital pathology, desktop medical slide scanner, whole slide imaging, virtual microscopy, and remote medical collaboration systems. It develops whole slide scanning systems such as mikroscan, q-scan, qumulus cloud, and deployment applications for digital pathology, biology, and research applications.
-
3DHISTECH LTD - The company’s products includes digital slide scanners offering fluorescent digital slides and high-quality bright field, tissue microarray machinery, and digital histology software. It is a manufacturer of high-performance hardware and software technologies for digital pathology.
-
Inspirata, Inc. – Inspirata’sautomated pathology and cancer informatics solutions have been used by than more 30 hospitals & laboratories to classify cancer in over 20 million patients. The company aims to focus on the right perspectives in converting more cancer patients to cancer survivors.
-
Visiopharm A/S - Visiopharm A/S provides augmented pathology solutions that include precision pathology and high-throughput pathology for research & tissue diagnostics. The company has ventured into AI and deep learning for configurable solutions for tissue analysis.
-
Huron Technologies International, Inc. - Huron Technologies International, Inc. provides easy-to-use tools for researchers, educators, and pathologists for retrieving images. Its pathology portfolio combines powerful image search technology with whole slide imaging hardware to connect pathologists and researchers for quick & effective diagnosis and disease research.
Value chain-based sizing & forecasting
Supply Side Estimates
-
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
-
Segment revenue determination via variable analysis and penetration modeling.
-
Competitive benchmarking to identify market leaders and their collective revenue shares.
-
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
-
Identifying parent markets and ancillary markets
-
Segment penetration analysis to obtain pertinent
-
revenue/volume
-
Heuristic forecasting with the help of subject matter experts
-
Forecasting via variable analysis
Digital Pathology Market Report Objectives:
-
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
-
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
-
Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
Digital Pathology Market Report Assumptions:
-
The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
-
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
-
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
-
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
-
Inflation has not been accounted for to estimate and forecast the market.
-
Numbers may not add up due to rounding off.
-
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
-
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
-
Latin America includes Central American countries and the South American continent
-
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
Primary Research
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
-
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
-
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
![pdf icn]()
GET A FREE SAMPLE
![arrow icn]()
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.
![gvr icn]()
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
![Certified Icon]()
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
